RecallDepth
Class III Terminated

Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10

Company
Fresenius Kabi Usa, Llc
Recall Initiated
July 13, 2020
Posted
July 22, 2020
Recall Number
D-1391-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
63,067 vials
Firm Location
Lake Zurich, IL, United States

Reason for Recall

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 6122760, 6122761, exp 08/2021; 6122762, exp 09/2021; 6123883, exp 03/2022

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class III Drug recalls